Global Health Ltd
MEDANTA • Health Care
ROCE
19.15%
FY24 Actual
D/E Ratio
0.21
Leveraged
5Y Rev CAGR
25.0%
High Growth
Profit Margin
| Metrics (Values in Cr) | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 2,205.82 | 2,759.17(+25.1%) |
MEDANTA • Health Care
ROCE
19.15%
FY24 Actual
D/E Ratio
0.21
Leveraged
5Y Rev CAGR
25.0%
High Growth
Profit Margin
| Metrics (Values in Cr) | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 2,205.82 | 2,759.17(+25.1%) |
12.0%
5Y Average
3,771.42(+12.6%) |
4,508.86(+19.6%) |
4,524.84 |
| Operating Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Operating Profit | — | — | — | — | — | — |
| Raw Profit | 545.75 | 626.86(+14.9%) | 761.65(+21.5%) | 882.42(+15.9%) | — | — |
| Operating Expenses | 103.9 | 130.83(+25.9%) | 150.48(+15.0%) | 205.47(+36.5%) | 3,492.19(+1599.6%) | 3,508.17 |
| Selling General And Administrative Expenses | 444.56 | 623.16(+40.2%) | 759.27(+21.8%) | 881.51(+16.1%) | — | — |
| Depreciation And Amortization | 129.71 | 149.92(+15.6%) | 172.73(+15.2%) | 193.75(+12.2%) | 222.54(+14.9%) | 222.55 |
| Profit Before Interest | 366.88 | 535.63(+46.0%) | 710.87(+32.7%) | 721.61(+1.5%) | 794.13(+10.0%) | 794.12 |
| Interest Expense | 86.32 | 86.33(+0.0%) | 83.78(-3.0%) | 74.35(-11.3%) | 79.11(+6.4%) | 79.12 |
| Profit Before Tax | 280.56 | 449.3(+60.1%) | 627.09(+39.6%) | 647.26(+3.2%) | 715.02(+10.5%) | 715 |
| Tax Expense | 84.36 | 123.21(+46.1%) | 148.91(+20.9%) | 165.82(+11.4%) | 158.56(-4.4%) | 158.55 |
| Net Income | 196.2 | 326.09(+66.2%) | 478.18(+46.6%) | 481.44(+0.7%) | 556.46(+15.6%) | 556.45 |
| Earnings Per Share | 7.83 | 12.508(+59.7%) | 17.819(+42.5%) | 17.93(+0.6%) | 20.71(+15.5%) | 20.724 |
| Dividends Per Share | 0 | 0 | 0 | 0 | 0 | 0.5 |
| Payout Ratio | 0 | 0 | 0 | 0 | 0 | 0.024 |